{"id":5857,"date":"2026-04-05T17:11:06","date_gmt":"2026-04-05T11:41:06","guid":{"rendered":"https:\/\/nervnow.com\/?p=5857"},"modified":"2026-04-05T17:11:08","modified_gmt":"2026-04-05T11:41:08","slug":"is-ai-healthcare-really-reaching-tier-2-india","status":"publish","type":"post","link":"https:\/\/nervnow.com\/ro\/is-ai-healthcare-really-reaching-tier-2-india\/","title":{"rendered":"Is AI Healthcare Really Reaching Tier-2 India?"},"content":{"rendered":"<!DOCTYPE html>\n<html lang=\"en\">\n<head>\n<meta charset=\"UTF-8\">\n<meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\">\n<title>AI Diagnostics in Tier-2 India: The Access Story Nobody Has Actually Verified \u2013 NervNow<\/title>\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=DM+Serif+Display:ital@0;1&#038;family=Inter:wght@400;500;600;700&#038;family=Source+Serif+4:ital,wght@0,400;1,400&#038;display=swap\" rel=\"stylesheet\">\n<style>\n  :root {\n    --navy: #182a4f;\n    --cream: #f5f1ea;\n    --cream-text: #f0ebe0;\n    --near-black: #0f0f0e;\n    --mid-grey: #6b6b6a;\n    --light-grey: #e8e4dd;\n    --border: #d4cfc8;\n    --accent-red: #c0392b;\n  }\n\n  *, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }\n\n  body {\n    background: #ffffff;\n    color: var(--near-black);\n    font-family: 'Source Serif 4', Georgia, serif;\n    font-weight: 400;\n    line-height: 1.78;\n    font-size: 18px;\n    -webkit-font-smoothing: antialiased;\n  }\n\n  .site-header {\n    border-bottom: 1.5px solid var(--navy);\n    padding: 0 40px;\n    display: flex;\n    align-items: center;\n    justify-content: space-between;\n    height: 72px;\n    background: #fff;\n  }\n  .site-logo img {\n    height: 36px;\n    width: auto;\n    display: block;\n  }\n  .header-tag {\n    font-family: 'Inter', sans-serif;\n    font-size: 11px;\n    font-weight: 600;\n    letter-spacing: 0.12em;\n    text-transform: uppercase;\n    color: var(--mid-grey);\n  }\n\n  .article-wrapper {\n    max-width: 780px;\n    margin: 0 auto;\n    padding: 0 24px 80px;\n  }\n\n  .article-kicker {\n    margin-top: 52px;\n    margin-bottom: 18px;\n    display: flex;\n    align-items: center;\n    gap: 16px;\n  }\n  .kicker-label {\n    font-family: 'Inter', sans-serif;\n    font-size: 11px;\n    font-weight: 600;\n    letter-spacing: 0.13em;\n    text-transform: uppercase;\n    color: var(--navy);\n    border-left: 3px solid var(--navy);\n    padding-left: 10px;\n  }\n  .kicker-pipe { color: var(--border); font-weight: 300; }\n  .kicker-sub {\n    font-family: 'Inter', sans-serif;\n    font-size: 11px;\n    font-weight: 500;\n    letter-spacing: 0.1em;\n    text-transform: uppercase;\n    color: var(--mid-grey);\n  }\n\n  h1.article-title {\n    font-family: 'DM Serif Display', 'Georgia', serif;\n    font-size: clamp(32px, 5vw, 46px);\n    line-height: 1.14;\n    color: var(--navy);\n    letter-spacing: -0.01em;\n    font-weight: 400;\n    margin-bottom: 22px;\n  }\n\n  .article-deck {\n    font-family: 'Inter', sans-serif;\n    font-size: 17px;\n    font-weight: 400;\n    line-height: 1.6;\n    color: #3a3a39;\n    margin-bottom: 28px;\n    border-left: 3px solid var(--light-grey);\n    padding-left: 18px;\n  }\n\n  .article-byline {\n    font-family: 'Inter', sans-serif;\n    font-size: 13px;\n    color: var(--mid-grey);\n    margin-bottom: 12px;\n    display: flex;\n    gap: 20px;\n    flex-wrap: wrap;\n  }\n  .byline-bold { font-weight: 600; color: var(--near-black); }\n\n  .rule { border: none; border-top: 1.5px solid var(--border); margin: 32px 0; }\n\n  .stat-bar {\n    display: grid;\n    grid-template-columns: repeat(auto-fit, minmax(160px, 1fr));\n    gap: 1px;\n    background: var(--border);\n    border: 1px solid var(--border);\n    margin: 36px 0;\n  }\n  .stat-cell { background: #fff; padding: 22px 20px; text-align: center; }\n  .stat-number {\n    font-family: 'DM Serif Display', serif;\n    font-size: 34px;\n    color: var(--navy);\n    line-height: 1;\n    display: block;\n    margin-bottom: 8px;\n  }\n  .stat-label {\n    font-family: 'Inter', sans-serif;\n    font-size: 11.5px;\n    color: var(--mid-grey);\n    line-height: 1.45;\n    font-weight: 500;\n  }\n  .stat-source {\n    font-family: 'Inter', sans-serif;\n    font-size: 10px;\n    color: #aaa;\n    display: block;\n    margin-top: 5px;\n    font-style: italic;\n  }\n\n  .disclaimer {\n    font-family: 'Inter', sans-serif;\n    font-size: 12px;\n    color: var(--mid-grey);\n    background: #fafafa;\n    border: 1px solid var(--border);\n    padding: 14px 18px;\n    margin-bottom: 40px;\n    line-height: 1.6;\n  }\n\n  h2.section-label {\n    font-family: 'Inter', sans-serif;\n    font-size: 10.5px;\n    font-weight: 700;\n    letter-spacing: 0.15em;\n    text-transform: uppercase;\n    color: var(--mid-grey);\n    margin-top: 52px;\n    margin-bottom: 6px;\n  }\n  h3.section-head {\n    font-family: 'DM Serif Display', serif;\n    font-size: 27px;\n    color: var(--navy);\n    line-height: 1.22;\n    font-weight: 400;\n    margin-bottom: 20px;\n    letter-spacing: -0.005em;\n  }\n\n  p { margin-bottom: 22px; }\n\n  .pull-quote {\n    background: var(--navy);\n    padding: 30px 32px;\n    margin: 40px 0;\n  }\n  .pull-quote p {\n    font-family: 'DM Serif Display', serif;\n    font-size: 21px;\n    font-style: italic;\n    color: var(--cream-text);\n    line-height: 1.5;\n    margin-bottom: 0;\n  }\n\n  .case-box {\n    border: 1.5px solid var(--navy);\n    padding: 28px 30px;\n    margin: 36px 0;\n  }\n  .case-box-label {\n    font-family: 'Inter', sans-serif;\n    font-size: 10px;\n    font-weight: 700;\n    letter-spacing: 0.16em;\n    text-transform: uppercase;\n    color: var(--navy);\n    margin-bottom: 10px;\n    display: block;\n  }\n  .case-box h4 {\n    font-family: 'DM Serif Display', serif;\n    font-size: 20px;\n    color: var(--navy);\n    font-weight: 400;\n    margin-bottom: 16px;\n    line-height: 1.2;\n  }\n  .case-box p { font-size: 16.5px; margin-bottom: 14px; }\n  .case-box p:last-child { margin-bottom: 0; }\n\n  .data-table-wrap { overflow-x: auto; margin: 36px 0; }\n  table { width: 100%; border-collapse: collapse; font-family: 'Inter', sans-serif; font-size: 13.5px; }\n  thead tr { background: var(--navy); color: #fff; }\n  thead th {\n    padding: 12px 14px;\n    font-weight: 600;\n    font-size: 11px;\n    letter-spacing: 0.08em;\n    text-transform: uppercase;\n    text-align: left;\n  }\n  tbody tr:nth-child(even) { background: #fafaf9; }\n  tbody tr:hover { background: #f0ede8; }\n  tbody td {\n    padding: 11px 14px;\n    border-bottom: 1px solid var(--border);\n    line-height: 1.5;\n    vertical-align: top;\n  }\n  .td-win { color: #1a7a3c; font-weight: 600; font-size: 11px; }\n  .td-gap { color: var(--accent-red); font-weight: 600; font-size: 11px; }\n\n  .framework-box {\n    background: var(--cream);\n    border-top: 3px solid var(--navy);\n    padding: 30px 32px;\n    margin: 40px 0;\n  }\n  .framework-box h4 {\n    font-family: 'Inter', sans-serif;\n    font-size: 11px;\n    font-weight: 700;\n    letter-spacing: 0.14em;\n    text-transform: uppercase;\n    color: var(--navy);\n    margin-bottom: 16px;\n  }\n  .framework-item { display: flex; gap: 16px; margin-bottom: 18px; align-items: flex-start; }\n  .framework-item:last-child { margin-bottom: 0; }\n  .framework-num {\n    font-family: 'DM Serif Display', serif;\n    font-size: 22px;\n    color: var(--navy);\n    opacity: 0.35;\n    min-width: 28px;\n    line-height: 1.2;\n  }\n  .framework-text {\n    font-family: 'Inter', sans-serif;\n    font-size: 14.5px;\n    line-height: 1.6;\n    color: var(--near-black);\n  }\n  .framework-text strong { display: block; font-weight: 600; margin-bottom: 3px; color: var(--navy); }\n\n  .sources-block {\n    background: #fafaf9;\n    border: 1px solid var(--border);\n    padding: 24px 28px;\n    margin-top: 52px;\n  }\n  .sources-block h4 {\n    font-family: 'Inter', sans-serif;\n    font-size: 10px;\n    font-weight: 700;\n    letter-spacing: 0.15em;\n    text-transform: uppercase;\n    color: var(--mid-grey);\n    margin-bottom: 14px;\n  }\n  .sources-block ol { padding-left: 18px; }\n  .sources-block li {\n    font-family: 'Inter', sans-serif;\n    font-size: 12.5px;\n    color: var(--mid-grey);\n    line-height: 1.65;\n    margin-bottom: 7px;\n  }\n  .sources-block a { color: var(--navy); text-decoration: underline; text-underline-offset: 2px; }\n\n  .related-block { margin-top: 60px; padding-top: 28px; border-top: 1.5px solid var(--navy); }\n  .related-label {\n    font-family: 'Inter', sans-serif;\n    font-size: 10px;\n    font-weight: 700;\n    letter-spacing: 0.15em;\n    text-transform: uppercase;\n    color: var(--mid-grey);\n    margin-bottom: 18px;\n  }\n  .related-links { display: flex; flex-direction: column; gap: 12px; }\n  .related-link {\n    font-family: 'Inter', sans-serif;\n    font-size: 15px;\n    font-weight: 600;\n    color: var(--navy);\n    text-decoration: none;\n    line-height: 1.4;\n    padding-left: 14px;\n    border-left: 2px solid var(--border);\n    transition: border-color 0.2s;\n  }\n  .related-link:hover { border-left-color: var(--navy); }\n\n  .site-footer {\n    background: var(--navy);\n    color: rgba(255,255,255,0.55);\n    font-family: 'Inter', sans-serif;\n    font-size: 12px;\n    text-align: center;\n    padding: 28px 40px;\n    margin-top: 80px;\n  }\n  .site-footer a { color: rgba(255,255,255,0.7); text-decoration: none; }\n\n  @media (max-width: 600px) {\n    .site-header { padding: 0 20px; }\n    .article-wrapper { padding: 0 18px 60px; }\n    .stat-bar { grid-template-columns: 1fr 1fr; }\n    .pull-quote p { font-size: 18px; }\n  }\n<\/style>\n<\/head>\n<body>\n\n<header class=\"site-header\">\n  <a href=\"https:\/\/nervnow.com\/ro\/\" class=\"site-logo\">\n    <img decoding=\"async\" src=\"data:image\/png;base64,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\" alt=\"NervNow\">\n  <\/a>\n  <span class=\"header-tag\">Analysis\/HealthTech<\/span>\n<\/header>\n\n<main class=\"article-wrapper\">\n\n  <div class=\"article-kicker\">\n    <span class=\"kicker-label\">HealthTech Analysis<\/span>\n    <span class=\"kicker-pipe\">|<\/span>\n    <span class=\"kicker-sub\">AI Diagnostics &nbsp;&middot;&nbsp; April 2026<\/span>\n  <\/div>\n\n  <h1 class=\"article-title\">AI Diagnostics in Tier-2 India: The Access Story Nobody Has Actually Verified<\/h1>\n\n  <p class=\"article-deck\">Announced deployments and verified patient outcomes in AI radiology and screening outside metro India tell very different stories. Understanding that gap matters for every health system decision-maker evaluating these tools.<\/p>\n\n  <div class=\"article-byline\">\n    <span>By <span class=\"byline-bold\">NervNow Editorial<\/span><\/span>\n    <span>April 2026<\/span>\n    <span>Analysis\/HealthTech<\/span>\n  <\/div>\n\n  <hr class=\"rule\">\n\n  <div class=\"stat-bar\">\n    <div class=\"stat-cell\">\n      <span class=\"stat-number\">1:100,000<\/span>\n      <span class=\"stat-label\">Radiologist-to-patient ratio in India<\/span>\n      <span class=\"stat-source\">IRIA\/Medical Buyer, 2024<\/span>\n    <\/div>\n    <div class=\"stat-cell\">\n      <span class=\"stat-number\">15,000<\/span>\n      <span class=\"stat-label\">Estimated radiologists for 1.4 billion people<\/span>\n      <span class=\"stat-source\">Indian Radiological &amp; Imaging Association, 2024<\/span>\n    <\/div>\n    <div class=\"stat-cell\">\n      <span class=\"stat-number\">8 of 33<\/span>\n      <span class=\"stat-label\">Labs in Nagpur that could host AI software in a published study<\/span>\n      <span class=\"stat-source\">Vijayan et al., PLOS Digital Health, 2023<\/span>\n    <\/div>\n    <div class=\"stat-cell\">\n      <span class=\"stat-number\">15.8%<\/span>\n      <span class=\"stat-label\">Additional TB case yield from AI in that Nagpur program<\/span>\n      <span class=\"stat-source\">Vijayan et al., PLOS Digital Health, 2023<\/span>\n    <\/div>\n  <\/div>\n\n  <div class=\"disclaimer\"><strong>Disclaimer:<\/strong> This article has been researched and produced by the NervNow editorial and research team. All statistics are sourced. This brief is for informational purposes only and does not constitute clinical, financial, or strategic advice.<\/div>\n\n  <h2 class=\"section-label\">The Setup<\/h2>\n  <h3 class=\"section-head\">The Claim and the Evidence It Rests On<\/h3>\n\n  <p>Every major announcement about AI diagnostics in India eventually arrives at the same image: a patient in a small city, at a community hospital with no radiologist on staff, receiving a chest X-ray result that would otherwise have taken days or weeks. The AI reads the image in seconds. A finding is transmitted to a specialist by telemedicine. Treatment begins the same day. This is the access story that has circulated through investor decks, government press releases, and trade coverage for the better part of three years.<\/p>\n\n  <p>Several Indian companies have built technology toward that scenario. The evidence verifying it at population scale, outside metro India, in routine clinical settings rather than structured research pilots, is substantially thinner than the announcement volume suggests.<\/p>\n\n  <p>India&#8217;s underlying need is real and severe. Industry estimates place India&#8217;s radiologist count at roughly 15,000 to 20,000 for a population exceeding 1.4 billion, producing a radiologist-to-patient ratio of approximately 1:100,000. The US ratio is 1:10,000. The Indian Radiological and Imaging Association has described this as a massive diagnostic bottleneck, particularly in rural and semi-urban areas. Tier-2 and Tier-3 cities bear a disproportionate share of that burden. The majority of India&#8217;s practicing radiologists work in private centers and non-government hospitals in metropolitan areas. One expert, quoted in Medical Buyer, described the distribution as &#8220;quite asymmetric.&#8221; Rural areas frequently have none at all.<\/p>\n\n  <p>This shortage creates a genuine case for AI-assisted diagnostics. The question this article examines is whether the deployments announced to address it are delivering what they describe, and what the verified evidence actually shows.<\/p>\n\n  <hr class=\"rule\">\n\n  <h2 class=\"section-label\">What the Evidence Does Support<\/h2>\n  <h3 class=\"section-head\">TB Screening: The Most Documented Case in Indian AI Diagnostics<\/h3>\n\n  <p>The most extensively validated application of AI diagnostics in India, and among the most thoroughly documented anywhere in the Global South, is tuberculosis screening using AI-assisted chest X-ray interpretation. India accounts for 26 to 28 percent of the world&#8217;s annual TB burden, with an estimated 2.8 million new cases in 2023. The National TB Elimination Programme recommends chest X-ray combined with sputum testing as the standard diagnostic pathway. The constraint is that interpreting those X-rays requires radiologists, and the places with the highest TB burden tend to have the fewest radiologists.<\/p>\n\n  <p>Qure.ai&#8217;s qXR system is the most studied AI tool in this context. The software has CDSCO approval in India and was evaluated by the World Health Organization, which referenced it in its March 2021 TB screening guidelines. A Health Technology Assessment commissioned by the Department of Health Research and conducted by the Indian Institute of Public Health Gandhinagar found that qXR demonstrated specificity of 0.94 (95% CI: 0.92&#8211;0.97) at sensitivity at or above 95 percent, reducing the need for costly confirmatory molecular testing by 66 percent. A separate cost-effectiveness analysis found qXR to be cost-saving relative to radiologist-read pathways from a health-system perspective.<\/p>\n\n  <div class=\"case-box\">\n    <span class=\"case-box-label\">Case Study<\/span>\n    <h4>Nagpur TB Screening Program: What the Published Study Actually Shows<\/h4>\n    <p>Between December 2018 and February 2020, global health organization PATH implemented a TB REACH active case-finding program in Nagpur, Maharashtra, using qXR deployed across private chest X-ray laboratories. The program identified 10,481 presumptive TB individuals through informal healthcare providers. AI found 15.8 percent additional cases that radiologists had not identified as presumptive for TB. Of the 213 confirmed TB patients, 35 percent came through non-TB care pathways, such as orthopedic, gynecological, and pre-surgical X-rays, showing the tool&#8217;s value in incidental detection.<\/p>\n    <p>The implementation report, published in PLOS Digital Health in December 2023, documents the operational reality with equal clarity. Of 33 private X-ray laboratories mapped in Nagpur, only eight (24.2 percent) could be engaged. The remaining 25 were excluded because they lacked basic prerequisites: reliable internet connectivity, a local area network, or agreement for software installation. The local Radiology Association initially declined to approve qXR installation at its member facilities, citing unfamiliarity with AI and its regulatory status in India. The research team required multiple rounds of meetings and documentation sharing before the association agreed to participate. Internet connectivity problems continued to delay X-ray uploads throughout the program period.<\/p>\n    <p><strong>Source:<\/strong> Vijayan et al., PLOS Digital Health, December 2023. doi: 10.1371\/journal.pdig.0000404<\/p>\n  <\/div>\n\n  <p>The Ministry of Health and Family Welfare&#8217;s November 2025 parliamentary briefing provides the government&#8217;s own accounting of AI diagnostic tools in active deployment. MadhuNetrAI, an AI solution for diabetic retinopathy screening, has been implemented across 38 facilities in 11 states and assisted with screening of 14,000 retinal images, benefiting 7,100 patients. The &#8220;Cough Against TB&#8221; (CATB) AI solution, which analyzes smartphone-recorded cough audio for TB screening, has been used to screen over 162,000 individuals since March 2023, showing a 12 to 16 percent additional case yield in deployed geographies. Qure.ai, working with the India Health Fund across 139 health facilities since 2020, has screened over 120,000 individuals. Peripheral hospitals in that program recorded a 12 percent increase in TB notifications compared to prior years.<\/p>\n\n  <p>These are real numbers from real programs. They represent a meaningful start. The correct reading of them, however, is that they are early-stage, NGO-supported, or government-program deployments. They do not describe independent commercial or routine clinical adoption across Tier-2 India at anything approaching population scale.<\/p>\n\n  <div class=\"pull-quote\">\n    <p>The TB screening evidence from India is among the most credible AI diagnostics data anywhere in the Global South. It also demonstrates, in the same papers that show efficacy, exactly why scale is harder than deployment announcements suggest.<\/p>\n  <\/div>\n\n  <hr class=\"rule\">\n\n  <h2 class=\"section-label\">The Infrastructure Reality<\/h2>\n  <h3 class=\"section-head\">What Happens When AI Meets the Ground<\/h3>\n\n  <p>The Nagpur study is instructive precisely because it is an unusually transparent account of an AI deployment in a resource-constrained Indian city. Most deployment announcements do not discuss how many facilities were excluded, why they were excluded, or what workarounds were required to make the remaining ones functional. The Nagpur paper does, and its candor reveals the gap between deployment-stage feasibility and routine clinical operation.<\/p>\n\n  <p>Of the three barriers documented in Nagpur, internet connectivity was the most persistent. qXR requires X-ray images to be uploaded to a cloud system for processing and reporting. Laboratories in smaller Indian cities frequently have unreliable or inadequate internet infrastructure. The research team had to design alternative upload workflows and provide technical support throughout the implementation period. The DICOM viewer software required by the system also had to be separately installed, and obtaining administrative rights to computers in private labs created additional delays. These are routine conditions of private diagnostic infrastructure in Tier-2 India.<\/p>\n\n  <p>A 2023 systematic review published in The Lancet Regional Health, examining teleradiology and technology innovations in Indian primary healthcare settings, reached a conclusion that applies equally to AI diagnostics: while the evidence base supports the potential of these technologies, there is insufficient data on the scale of teleradiology networks within India, needs assessments, costs, and barriers to implementation in primary healthcare settings. The review covered data from only 10 Indian states, with nine studies from rural settings, reflecting how thin the evidence base is outside structured programs.<\/p>\n\n  <p>The fragmentation of India&#8217;s diagnostic sector compounds the infrastructure problem. Approximately 100,000 diagnostic laboratories operate across the country, according to market research compiled by ResearchAndMarkets. The market is highly decentralized, comprising a mix of national chains, regional players, standalone labs, and hospital-based diagnostic centers. This fragmentation creates difficulties in achieving scalability and maintaining quality, particularly for smaller labs in Tier-3 cities. An AI vendor selling to this market is selling, facility by facility, to owners with varying technical capacity, internet reliability, and willingness to adopt new workflows.<\/p>\n\n  <p>A 2024 systematic review published in Nature&#8217;s Humanities and Social Sciences Communications, examining digital health implementation barriers in India across 26 studies, identified restricted internet connectivity and inadequate medical equipment as the country&#8217;s primary infrastructural problems. The review noted that few district hospitals have an electronic health record system, and that primary healthcare clinics lack basic physical infrastructure, including computers with internet connections. AI diagnostic tools built for cloud-based image processing sit on top of this infrastructure. When the infrastructure is absent, the tool is inoperable.<\/p>\n\n  <hr class=\"rule\">\n\n  <h2 class=\"section-label\">The Regulatory Landscape<\/h2>\n  <h3 class=\"section-head\">A Framework Under Construction<\/h3>\n\n  <p>India&#8217;s regulatory environment for AI medical devices has been evolving rapidly, but it reached a meaningful threshold only recently. On Oct. 21, 2025, the Central Drugs Standard Control Organisation (CDSCO) released a draft guidance document on Medical Device Software, establishing for the first time a structured, risk-based framework for classifying and licensing software-based medical devices. Under this draft, AI-powered radiology tools are classified as Software as a Medical Device (SaMD), with tools performing diagnostic functions in moderate-to-high-risk clinical scenarios classified as Class C devices.<\/p>\n\n  <p>Before this guidance, the regulatory picture was substantially murkier. Under the Medical Device Rules 2017, software that performs a medical function was technically classified as a medical device, but the existing framework lacked specific direction on risk classification, licensing procedures, algorithm validation, cybersecurity requirements, and post-deployment performance monitoring. CDSCO had approved some tools, including qXR under license number MFG\/MD\/2023\/000181, but the approval pathway was inconsistently understood across the industry.<\/p>\n\n  <p>The October 2025 draft guidance does not create new regulatory requirements. It clarifies how existing provisions apply. Its significance lies in signaling a more structured approach, including specific provisions for managing machine learning-based algorithms, requirements for algorithm change protocols, and post-market surveillance obligations. Stakeholders, led by the Medical Technology Association of India, have largely welcomed the guidance but have requested further clarity on how AI model drift should be assessed, how periodic algorithm re-validation should be structured, and how real-world performance monitoring should be reported. These are substantive open questions. An AI diagnostic tool trained on data from one population or imaging machine may perform differently when deployed on different equipment in a different geography, and India&#8217;s imaging infrastructure varies considerably across cities.<\/p>\n\n  <hr class=\"rule\">\n\n  <h2 class=\"section-label\">The Announcement Gap<\/h2>\n  <h3 class=\"section-head\">What Companies Report vs. What the Evidence Shows<\/h3>\n\n  <p>The gap between announcement and evidence in Indian AI diagnostics does not reflect dishonesty in most cases. It reflects the incentives of the announcement cycle. A startup that deploys across 139 facilities in partnership with an NGO issues a press release about transforming TB care in India. A vendor whose tool has been approved by CDSCO and cited by WHO issues a press release about revolutionizing diagnostics. These statements are technically true. They are also systematically incomplete. The facilities served are often selected for above-average infrastructure. The programs are typically supported by NGO funding or government initiative, not commercial procurement. The outcomes reported are from the program period, not from sustained routine operation thereafter.<\/p>\n\n  <p>Fujifilm India&#8217;s 2025 disclosure sits at the better end of this pattern. The company reported screening over 125,000 individuals for TB across 15 states, and reaching over 100,000 women through breast cancer awareness and screening campaigns, through partnerships with governments, NGOs, and diagnostic chains. This is a significant operational achievement. It is also a description of partnership-driven programs. Programs that depend on partnerships and external funding do not automatically convert into routine care once the program ends.<\/p>\n\n  <p>The market sizing data tells a related story. India&#8217;s AI in Medical Diagnostics market was valued at $12.87 million in 2024 and is projected to reach $44.87 million by 2030, according to research cited by GlobeNewswire. These are real numbers, though small ones for a country of 1.4 billion. The market currently operates at a scale that reflects early adoption in structured programs, not widespread independent clinical deployment. AI market concentration in southern India, particularly in Bangalore, Chennai, and Hyderabad, reflects where AI infrastructure, top-tier hospitals, and research facilities are located. That is roughly the opposite of where the radiologist shortage is most acute.<\/p>\n\n  <div class=\"pull-quote\">\n    <p>India&#8217;s AI diagnostics market was valued at $12.87 million in 2024 for a country of 1.4 billion people. The gap between that number and the announcement volume is itself a data point worth examining.<\/p>\n  <\/div>\n\n  <p>The government&#8217;s own position, stated by Union Minister Anupriya Patel at the Health of India Summit 2026, is that fears of AI replacing doctors are largely misplaced and the goal is augmentation. In the same period, multiple industry experts speaking to Business Standard ahead of Budget 2026 described AI tool adoption in routine care as slow, with the barrier identified not as technology but as the absence of clear pathways for scaling validated solutions. Qure.ai CEO Prashant Warier called for a time-bound national regulatory pathway for clinical AI and dedicated funding for deploying AI within public health systems. This is not the language of a sector that has solved deployment at scale. It is the language of one that has established proof of concept and is pressing government to build the infrastructure for the next stage.<\/p>\n\n  <hr class=\"rule\">\n\n  <h2 class=\"section-label\">Where Things Stand<\/h2>\n  <h3 class=\"section-head\">The Evidence Map Across Use Cases<\/h3>\n\n  <div class=\"data-table-wrap\">\n    <table>\n      <thead>\n        <tr>\n          <th>Use Case<\/th>\n          <th>Strongest Evidence<\/th>\n          <th>Evidence Quality<\/th>\n          <th>Tier-2\/3 Deployment Reality<\/th>\n          <th>Verification Status<\/th>\n        <\/tr>\n      <\/thead>\n      <tbody>\n        <tr>\n          <td><strong>TB chest X-ray screening (qXR)<\/strong><\/td>\n          <td>HTA by IIPHG; Vijayan et al. PLOS 2023; WHO 2021 guidelines<\/td>\n          <td>Strongest in category; peer-reviewed, government-commissioned<\/td>\n          <td>Active in Maharashtra, Gujarat, Chhattisgarh, Karnataka districts via NTEP and NGO programs<\/td>\n          <td class=\"td-win\">Verified with caveats: infrastructure barriers documented in same papers<\/td>\n        <\/tr>\n        <tr>\n          <td><strong>Diabetic retinopathy (MadhuNetrAI)<\/strong><\/td>\n          <td>MoHFW November 2025 briefing; 7,100 patients, 38 facilities, 11 states<\/td>\n          <td>Government-reported; independent peer-reviewed validation not yet published at scale<\/td>\n          <td>Active in 38 facilities, non-specialist operated; early stage<\/td>\n          <td class=\"td-gap\">Partially verified: government-reported outcomes, limited independent data<\/td>\n        <\/tr>\n        <tr>\n          <td><strong>TB cough screening (CATB\/Wadhwani AI)<\/strong><\/td>\n          <td>MoHFW briefing; 162,000 individuals screened; 12&#8211;16% additional yield<\/td>\n          <td>Government-reported; independent external validation ongoing<\/td>\n          <td>Community settings via NTEP<\/td>\n          <td class=\"td-gap\">Partially verified: deployment real, peer-reviewed outcome data limited<\/td>\n        <\/tr>\n        <tr>\n          <td><strong>General radiology AI (chest, fracture, other)<\/strong><\/td>\n          <td>KMC Manipal: 20&#8211;30 more patients per day (Philips AI-enabled CT); 5C Network pre-print on 50% reporting time reduction<\/td>\n          <td>Single-institution; Manipal is a tertiary center; 5C Network paper pre-print, not yet peer-reviewed<\/td>\n          <td>Concentrated in Tier-1 and large private Tier-2 hospitals with PACS infrastructure<\/td>\n          <td class=\"td-gap\">Evidence from well-resourced private centers; not verified at average Tier-2 scale<\/td>\n        <\/tr>\n        <tr>\n          <td><strong>Breast cancer screening (Niramai thermal imaging)<\/strong><\/td>\n          <td>Company-reported; no large independent trial published<\/td>\n          <td>Limited public peer-reviewed data; described in market reports<\/td>\n          <td>Deployment claimed across urban and semi-urban settings; independent verification limited<\/td>\n          <td class=\"td-gap\">Not independently verified at Tier-2 scale<\/td>\n        <\/tr>\n        <tr>\n          <td><strong>Stroke AI triage (Qure.ai stroke suite)<\/strong><\/td>\n          <td>Initial real-world studies cited; FDA clearances received; hub-and-spoke model described<\/td>\n          <td>Primarily metro\/tertiary hospital evidence; Tier-2 data not separately published<\/td>\n          <td>Requires CT infrastructure and stable connectivity<\/td>\n          <td class=\"td-gap\">Metro-verified; Tier-2 specific data not available<\/td>\n        <\/tr>\n      <\/tbody>\n    <\/table>\n  <\/div>\n\n  <hr class=\"rule\">\n\n  <h2 class=\"section-label\">The Structural Problems<\/h2>\n  <h3 class=\"section-head\">Why Deployment Is Not the Same as Access<\/h3>\n\n  <p>A category of claim in Indian AI healthcare presents deployment as equivalent to access. Deployment means a software license has been sold and installed. Access means a patient who previously could not get a timely diagnostic report can now get one. The distance between those two outcomes is filled by connectivity, trained operators, functional imaging equipment, a working PACS or DICOM-compatible workflow, a radiologist or physician available to review and act on AI findings, and the follow-up infrastructure to refer, treat, or monitor the patient once a result is made.<\/p>\n\n  <p>Each of those links can break. Several of them routinely do, at exactly the kind of facility where the access story is most needed. A district hospital in Chhattisgarh that lacks reliable internet cannot upload images for cloud-based analysis. A community health center in Rajasthan with a chest X-ray machine but no PACS system cannot integrate a software-as-a-medical-device tool without significant additional investment. A private lab whose radiologist already reads 100-plus scans per day may install AI as a workflow aid but will still face the same volume constraints on the review and reporting step.<\/p>\n\n  <p>The Lancet scoping review on teleradiology in Indian primary healthcare concluded in 2023 that there is insufficient data on the scale of teleradiology networks within India, on needs assessments, costs, and barriers to implementation in primary healthcare settings. That conclusion applies equally to AI-specific deployments. The evidence that exists is concentrated in structured programs with defined populations, NGO or government support, and dedicated technical assistance. The evidence for routine, unassisted, commercial-scale deployment at Tier-2 facilities with average infrastructure does not yet exist in sufficient quantity to support the access claims being made.<\/p>\n\n  <p>The clinician hesitancy documented in the Nagpur study adds a dimension that market forecasts tend to overlook. The local Radiology Association&#8217;s initial refusal to permit qXR installation at member labs was not irrational. Radiologists in India carry professional and legal exposure for diagnostic errors. A tool that flags abnormalities they must then review and sign off on raises questions about their liability if the AI is wrong, about their professional standing if the AI is perceived as replacing their role, and about patient data privacy in the absence of clear regulations. Those concerns are not resolved by CDSCO approval or WHO endorsement alone. They require sustained engagement, education, and regulatory clarity, all of which take time and resources that most commercial AI deployments do not budget for.<\/p>\n\n  <hr class=\"rule\">\n\n  <h2 class=\"section-label\">For Decision-Makers<\/h2>\n  <h3 class=\"section-head\">What Verified Evidence Supports and What It Does Not<\/h3>\n\n  <p>The distinction that matters for health system executives, government procurement officers, and enterprise buyers evaluating AI diagnostic vendors is between what has been peer-reviewed and independently verified, and what has been reported by the same company that has a financial interest in the outcome.<\/p>\n\n  <p>The TB chest X-ray application has the strongest evidence base. qXR has demonstrated radiologist-level sensitivity in multiple studies, has a government-commissioned HTA confirming cost-effectiveness, and has documented real-world deployment across hundreds of Indian sites. The limitations, including connectivity requirements, radiologist buy-in, and infrastructure prerequisites, are documented in the same literature. Buyers can make an informed decision about whether those limitations apply to their context.<\/p>\n\n  <p>General radiology AI for chest abnormalities, fracture detection, and incidental findings has strong technical performance data in controlled studies and single-institution pilots. The evidence for cost-effective, routine deployment in average-infrastructure Tier-2 hospitals is not yet available at the scale required to draw firm conclusions. The evidence from KMC Manipal, a major private tertiary center, does not transfer to a district hospital in Madhya Pradesh.<\/p>\n\n  <p>For most other applications, including breast cancer screening with thermal imaging, stroke AI triage in non-metro settings, and diabetic retinopathy at community health centers, the accurate characterization is that promising programs exist, early data are encouraging, and the independent peer-reviewed evidence base to support large-scale procurement decisions is still being assembled.<\/p>\n\n  <div class=\"framework-box\">\n    <h4>Five Questions for Buyers Evaluating AI Diagnostic Claims in India<\/h4>\n    <div class=\"framework-item\">\n      <span class=\"framework-num\">1<\/span>\n      <div class=\"framework-text\">\n        <strong>Is the evidence from peer-reviewed studies or company-published data?<\/strong>\n        Health technology assessments commissioned by government bodies (such as the IIPHG\/DHR assessment of qXR) carry a different evidentiary weight than vendor case studies or press releases.\n      <\/div>\n    <\/div>\n    <div class=\"framework-item\">\n      <span class=\"framework-num\">2<\/span>\n      <div class=\"framework-text\">\n        <strong>Was the evidence generated at facilities comparable to yours?<\/strong>\n        Performance data from a tertiary private hospital with a full PACS system and reliable internet does not predict performance at a district hospital or standalone diagnostic lab.\n      <\/div>\n    <\/div>\n    <div class=\"framework-item\">\n      <span class=\"framework-num\">3<\/span>\n      <div class=\"framework-text\">\n        <strong>What percentage of target facilities could actually host the tool?<\/strong>\n        In the Nagpur program, 24.2 percent of mapped labs qualified. If a vendor cannot tell you what proportion of comparable facilities in your geography meet their technical prerequisites, the deployment projections are speculative.\n      <\/div>\n    <\/div>\n    <div class=\"framework-item\">\n      <span class=\"framework-num\">4<\/span>\n      <div class=\"framework-text\">\n        <strong>What does the follow-up pathway look like after a positive AI finding?<\/strong>\n        AI diagnostics generate findings. Those findings require clinician review, patient notification, and referral or treatment. If that downstream pathway does not exist or is not funded, the detection rate does not translate into patient outcomes.\n      <\/div>\n    <\/div>\n    <div class=\"framework-item\">\n      <span class=\"framework-num\">5<\/span>\n      <div class=\"framework-text\">\n        <strong>Has the regulatory classification been confirmed under CDSCO&#8217;s October 2025 draft guidance?<\/strong>\n        AI radiology tools are Class C SaMD under the new framework, requiring Central Licensing Authority approval and post-market surveillance obligations. Verify that any tool under evaluation has or is clearly on track for the appropriate regulatory standing.\n      <\/div>\n    <\/div>\n  <\/div>\n\n  <p>The access story being told about AI diagnostics in Tier-2 India is not false. The technology works in the contexts where it has been rigorously deployed. The radiologist shortage is severe enough that even partial solutions matter. What the evidence does not yet support is the leap from programs are underway to the access problem is being addressed at scale. Those are different claims, and the distance between them is where the real work of the next five years in Indian health AI will take place.<\/p>\n\n  <div class=\"pull-quote\">\n    <p>The question for India&#8217;s AI diagnostics sector is not whether the technology works. In structured programs with adequate infrastructure, it does. The question is whether deployment at the facilities that most need it is feasible without the NGO support, government partnerships, and dedicated technical teams that the existing evidence rests on.<\/p>\n  <\/div>\n\n  <div class=\"sources-block\">\n    <h4>Sources<\/h4>\n    <ol>\n      <li>Vijayan S et al. &#8220;Implementing a chest X-ray artificial intelligence tool to enhance tuberculosis screening in India: Lessons learned.&#8221; PLOS Digital Health, December 2023. <a href=\"https:\/\/journals.plos.org\/digitalhealth\/article?id=10.1371\/journal.pdig.0000404\" target=\"_blank\">doi: 10.1371\/journal.pdig.0000404<\/a><\/li>\n      <li>Indian Institute of Public Health Gandhinagar (IIPHG). Health Technology Assessment: AI-Assisted CXR for Tuberculosis Screening. Department of Health Research, Government of India. <a href=\"https:\/\/htain.dhr.gov.in\/images\/pdf\/outcome_reports\/77.AI_Assisted_CXR.pdf\" target=\"_blank\">htain.dhr.gov.in<\/a><\/li>\n      <li>Indian Radiological and Imaging Association (IRIA), as cited in Medical Buyer. &#8220;India has alarming ratio of one radiologist per lakh people.&#8221; October 2023. <a href=\"https:\/\/medicalbuyer.co.in\/india-has-alarming-ratio-of-one-radiologist-per-lakh-people\/\" target=\"_blank\">medicalbuyer.co.in<\/a><\/li>\n      <li>Ministry of Health and Family Welfare, Government of India. &#8220;Steps taken to include AI-based diagnostic tools in healthcare.&#8221; November 2025. <a href=\"https:\/\/www.mohfw.gov.in\/?q=en\/pressrelease\/steps-taken-include-ai-based-diagnostic-tools-healthcare\" target=\"_blank\">mohfw.gov.in<\/a><\/li>\n      <li>&#8220;Teleradiology and technology innovations in radiology: status in India and its role in increasing access to primary health care.&#8221; The Lancet Regional Health, Southeast Asia, April 2023. <a href=\"https:\/\/www.thelancet.com\/journals\/lansea\/article\/PIIS2772-3682(23)00055-0\/fulltext\" target=\"_blank\">thelancet.com<\/a><\/li>\n      <li>&#8220;Barriers to implementation of digital transformation in the Indian health sector: a systematic review.&#8221; Humanities and Social Sciences Communications (Nature), May 2024. <a href=\"https:\/\/www.nature.com\/articles\/s41599-024-03081-7\" target=\"_blank\">nature.com<\/a><\/li>\n      <li>ResearchAndMarkets\/GlobeNewswire. &#8220;India AI in Medical Diagnostics Market 2025-2030.&#8221; March 2025. <a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/03\/07\/3038892\/0\/en\/India-s-AI-in-Medical-Diagnostics-Market-2025-2030-Market-Set-to-Triple-in-Size.html\" target=\"_blank\">globenewswire.com<\/a><\/li>\n      <li>CDSCO Draft Guidance on Medical Device Software, Oct. 21, 2025. Analysis: India Briefing, November 2025. <a href=\"https:\/\/www.india-briefing.com\/news\/cdsco-draft-guidance-medical-software-40691.html\/\" target=\"_blank\">india-briefing.com<\/a><\/li>\n      <li>Business Standard. &#8220;Budget 2026: Can investment in digital health and AI reshape healthcare?&#8221; January 2026. <a href=\"https:\/\/www.business-standard.com\/health\/budget-2026-digital-health-ai-investment-india-healthcare-126012300459_1.html\" target=\"_blank\">business-standard.com<\/a><\/li>\n      <li>Philips. &#8220;AI in radiology: three keys to real-world impact.&#8221; January 2026, citing KMC Manipal data. <a href=\"https:\/\/www.philips.com\/a-w\/about\/news\/archive\/features\/2025\/ai-in-radiology-three-keys-to-real-world-impact.html\" target=\"_blank\">philips.com<\/a><\/li>\n      <li>Qure.ai. &#8220;AI game changer in tracking cases of tuberculosis.&#8221; March 2024. <a href=\"https:\/\/www.qure.ai\/news_press_coverages\/artificial-intelligence-game-changer-in-tracking-cases-of-tuberculosis\" target=\"_blank\">qure.ai<\/a><\/li>\n      <li>Cyril Amarchand Blogs. &#8220;Medical Device as Software: Has CDSCO Guidance Changed the Rules?&#8221; January 2026. <a href=\"https:\/\/corporate.cyrilamarchandblogs.com\/2026\/01\/medical-device-as-software-has-cdsco-guidance-changed-the-rules\/\" target=\"_blank\">cyrilamarchandblogs.com<\/a><\/li>\n    <\/ol>\n  <\/div>\n\n  <div class=\"related-block\">\n    <div class=\"related-label\">More Deep Dives<\/div>\n    <div class=\"related-links\">\n      <a class=\"related-link\" href=\"https:\/\/nervnow.com\/ro\/are-indian-enterprises-paying-full-price-for-a-half-built-ai-product\/\">Are Indian Enterprises Paying Full Price for a Half-Built AI Product?<\/a>\n      <a class=\"related-link\" href=\"https:\/\/nervnow.com\/ro\/are-ai-chatbots-actually-improving-customer-experience-or-just-cutting-costs\/\">Are AI Chatbots Actually Improving Customer Experience, or Just Cutting Costs?<\/a>\n      <a class=\"related-link\" href=\"https:\/\/nervnow.com\/ro\/why-most-enterprises-hire-the-wrong-head-of-ai-and-what-to-do-instead\/\">Why Most Enterprises Hire the Wrong Head of AI and What to Do Instead<\/a>\n    <\/div>\n  <\/div>\n\n<\/main>\n\n<footer class=\"site-footer\">\n  &copy; 2026 NervNow&#8482;. All rights reserved. &nbsp;|&nbsp; <a href=\"https:\/\/nervnow.com\/ro\/\">nervnow.com<\/a> &nbsp;|&nbsp; AI intelligence for decision-makers.\n<\/footer>\n\n<\/body>\n<\/html>","protected":false},"excerpt":{"rendered":"<p>Announced deployments and verified patient outcomes in AI radiology and screening outside metro India tell very different stories. Understanding that gap matters for every health system decision-maker evaluating these tools.<\/p>","protected":false},"author":6,"featured_media":5863,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_gspb_post_css":"","om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[95,111],"tags":[183],"class_list":["post-5857","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analysis","category-analysis-industries-healthtech","tag-analysis"],"blocksy_meta":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/posts\/5857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/comments?post=5857"}],"version-history":[{"count":1,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/posts\/5857\/revisions"}],"predecessor-version":[{"id":5864,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/posts\/5857\/revisions\/5864"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/media\/5863"}],"wp:attachment":[{"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/media?parent=5857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/categories?post=5857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/tags?post=5857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}